Executive Director
LifeNet Health
Kalamazoo, Michigan
James McKim, Ph.D. is the Executive Director of Cell-Based In Vitro Assay Services at LifeNet
Health Lifesciences. Jim is trained as a biochemical and molecular toxicologist. He was an
Assistant Professor at the University of Colorado School of Medicine where his research focused
on children’s liver disease processes. He then took a position as group leader for Biochemical
Toxicology at Dow Corning Corporation. He then moved to Pharmacia Corporation where he
headed the first in vitro testing program designed to identify liabilities of new drug candidates in
early discovery. Dr. McKim is a founder, President and CEO of multiple biotechnology
companies including CeeTox and IONTOX. CeeTox was founded on an in vitro model that
estimated small molecule systemic toxicity. Dr. McKim also founded IONTOX, LLC a
company focused on the development and characterization of new in vitro testing platforms.
Recently, he managed the sale of IONTOX to LifeNet Health. Dr. McKim is a Research
Associate Professor at the Western Michigan Homer Stryker School of Medicine in the
department of Biomedical Sciences. He is a diplomat of the American board of Toxicology and
the founding Editor in Chief of Applied In Vitro Toxicology.
Disclosure information not submitted.
Monday, October 17, 2022
12:30 PM – 1:30 PM ET